Seeking Alpha

Reuters: Carlyle near deal to buy J&J's clinical diagnostics unit

  • Carlyle Group (CG) appears to be the leader to acquire Johnson & Johnson's (JNJ) clinical diagnostics unit, beating out P-E peer Blackstone (BX) and its partner Danaher (DHR), Reuters reports.
  • The exact price of CG's offer is not known, but a deal likely would fetch ~$4B and could be completed within the next two weeks.
  • JNJ's ortho clinical diagnostics unit makes blood-screening equipment and laboratory blood tests; it's a small player in a market led by Roche (RHHBY, RHHBF), Siemens (SI), Abbott Labs (ABT) and DHR.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)